Drug Trial Radar · NCT02344498
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa
Last checked: Nov 19, 2026Latest source record: Nov 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
7,350
Actual
Start
Jan 2015
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Oslo University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Addis Ababa University; The Research Council of Norway; University of Agder; South-Eastern Norway Regional Health Authority; St. Paul's Hospital Millennium Medical College, Ethiopia; Haramaya University,Ethiopia
- First posted
- Jan 26, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Viral hepatitis kills nearly one million people each year, even though effective treatment exists. The aim of this study is to establish a treatment protocol for hepatitis B, which is simple and cheap enough to be implemented in resource-limited settings.
Conditions
- Hepatitis B
Interventions
Tenofovir disoproxilDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Death, HCC or decompensated cirrhosisTime frame: 3 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
St Paul Hospital Millennium Medical College
Addis Ababa, Addis Ababa, Ethiopia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.